Return to Today's science sparks archives

2013-01-02

Fig 1. Altruistic cell death as a social interaction that enhances collective stress resistance.

Fig 1. Altruistic cell death as a social interaction that enhances collective stress resistance.
  • Carmona-Fontaine C, Xavier JB

  • Mol Syst Biol. 2012 Nov 20;8:627.
Open Access button

2013-01-03

Figure 11. (A) A markedly lobulated PA of the parotid. Compare with Figure 1 and with recurrent PA. (B) Although most of the recurrent tumor consists of variously confluent stroma-rich nodules (asterisk), 1 nodule is parenchyma rich (arrow).

Figure 11. (A) A markedly lobulated PA of the parotid. Compare with Figure 1 and with recurrent PA. (B) Although most of the recurrent tumor consists of variously confluent stroma-rich nodules (asterisk), 1 nodule is parenchyma rich (arrow).
  • Zbären P, Vander Poorten V, Witt RL, Woolgar JA, Shaha AR, Triantafyllou A, Takes RP, Rinaldo A, Ferlito A

  • Am J Surg. 2013 Jan;205(1):109-18.

2013-01-04

Fig. 1. Local failure-free survival for all patients.

Fig. 1. Local failure-free survival for all patients.
  • Yang JC, Wexler LH, Meyers PA, Wolden SL

  • Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e61-6.

2013-01-07

Supplementary Figure 1. Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) analysis of Gli1, Gli2, and Gli3 in normal intestine (n = 6) and in tumors (n = 8) of Ptchflox/floxLysMcre+/- mice.

Supplementary Figure 1. Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) analysis of Gli1, Gli2, and Gli3 in normal intestine (n = 6) and in tumors (n = 8) of Ptchflox/floxLysMcre+/- mice.
  • Pelczar P, Zibat A, van Dop WA, Heijmans J, Bleckmann A, Gruber W, Nitzki F, Uhmann A, Guijarro MV, Hernando E, Dittmann K, Wienands J, Dressel R, Wojnowski L, Binder C, Taguchi T, Beissbarth T, Hogendoorn PC, Antonescu CR, Rubin BP, Schulz-Schaeffer W, Aberger F, van den Brink GR, Hahn H

  • Gastroenterology. 2013 Jan;144(1):134-144.e6.

2013-01-08

Fig. 1. Median values and envelopes containing the central 68% and 95% distributions of generalized equivalent uniform dose.

Fig. 1. Median values and envelopes containing the central 68% and 95% distributions of generalized equivalent uniform dose.
  • Liu F, Yorke ED, Belderbos JS, Borst GR, Rosenzweig KE, Lebesque JV, Jackson A

  • Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):182-9.

2013-01-09

Fig 3. (a) Uptake of several carbon nanotube Raman modes measured within a live macrophage.

Fig 3. (a) Uptake of several carbon nanotube Raman modes measured within a live macrophage.
  • Kang JW, Nguyen FT, Lue N, Dasari RR, Heller DA

  • Nano Lett. 2012 Dec 12;12(12):6170-4.

2013-01-10

Fig 2. Unsupervised hierarchical clustering of microRNAs derived from lung metastasis samples distinguishes patients with high vs. low rates of metastatic progression.

Fig 2. Unsupervised hierarchical clustering of microRNAs derived from lung metastasis samples distinguishes patients with high vs. low rates of metastatic progression.
  • Lussier YA, Khodarev NN, Regan K, Corbin K, Li H, Ganai S, Khan SA, Gnerlich J, Darga TE, Fan H, Karpenko O, Paty PB, Posner MC, Chmura SJ, Hellman S, Ferguson MK, Weichselbaum RR

  • PLoS One. 2012;7(12):e50141
Open Access button

2013-01-11

Fig 1. MEF in Human and Mouse Gliomas. (B) Kaplan Meier survival curves of TCGA GBM patients: low level of MEF (calculated as less than one standard deviation from the mean of diploid tumors) significantly correlates with better overall survival (∗∗∗log-rank p value, p = 0.000386).

Fig 1. MEF in Human and Mouse Gliomas. (B) Kaplan Meier survival curves of TCGA GBM patients: low level of MEF (calculated as less than one standard deviation from the mean of diploid tumors) significantly correlates with better overall survival (∗∗∗log-rank p value, p = 0.000386).
  • Bazzoli E, Pulvirenti T, Oberstadt MC, Perna F, Wee B, Schultz N, Huse JT, Fomchenko EI, Voza F, Tabar V, Brennan CW, Deangelis LM, Nimer SD, Holland EC, Squatrito M

  • Cell Stem Cell. 2012 Dec 7;11(6):836-844.

2013-01-14

Fig 2. Argonaute Binding to Coding Regions. (B) Examples of AGO binding sites in the coding region. Coordinates along the x axis indicate nucleotide position relative to the beginning of the transcript.

Fig 2. Argonaute Binding to Coding Regions. (B) Examples of AGO binding sites in the coding region. Coordinates along the x axis indicate nucleotide position relative to the beginning of the transcript.
  • Loeb GB, Khan AA, Canner D, Hiatt JB, Shendure J, Darnell RB, Leslie CS, Rudensky AY

  • Mol Cell. 2012 Dec 14;48(5):760-70.

2013-01-15

Fig 2. Percent weight loss is shown by time point for all patients.

Fig 2. Percent weight loss is shown by time point for all patients.
  • Romesser PB, Romanyshyn JC, Schupak KD, Setton J, Riaz N, Wolden SL, Gelblum DY, Sherman EJ, Kraus D, Lee NY

  • Cancer. 2012 Dec 15;118(24):6072-8.

2013-01-16

Fig 1a. Schematic of chromosome segregation.

Fig 1a. Schematic of chromosome segregation.
  • Foley EA, Kapoor TM

  • Nat Rev Mol Cell Biol. 2013 Jan;14(1):25-37.

2013-01-17

Fig 1. 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) scans at baseline (left) and after one cycle (4 weeks) of treatment with BIIB021 400 mg TIW.

Fig 1. 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) scans at baseline (left) and after one cycle (4 weeks) of treatment with BIIB021 400 mg TIW.
  • Dickson MA, Okuno SH, Keohan ML, Maki RG, D'Adamo DR, Akhurst TJ, Antonescu CR, Schwartz GK

  • Ann Oncol. 2013 Jan;24(1):252-7.

2013-01-18

Fig 2. Waterfall plot of the change in the sum of the longest diameters of target lesions at time of best response using RECIST v1.1.

Fig 2. Waterfall plot of the change in the sum of the longest diameters of target lesions at time of best response using RECIST v1.1.
  • Matulonis UA, Lee J, Lasonde B, Tew WP, Yehwalashet A, Matei D, Behbakht K, Grothusen J, Fleming G, Lee NK, Arnott J, Bray MR, Fletcher G, Brokx RD, Castonguay V, Mackay H, Sidor CF, Oza AM

  • Eur J Cancer. 2013 Jan;49(1):121-31.

2013-01-21

Fgf4 is not required for initial expression of GATA6 but is crucial for its PrE lineage restriction.

Fgf4 is not required for initial expression of GATA6 but is crucial for its PrE lineage restriction.
  • Kang M, Piliszek A, Artus J, Hadjantonakis AK

  • Development. 2013 Jan;140(2):267-79.

2013-01-22

Fig 1a. Complete absence of staining with presence of positive internal control.

Fig 1a. Complete absence of staining with presence of positive internal control.
  • Garg K, Levine DA, Olvera N, Dao F, Bisogna M, Secord AA, Berchuck A, Cerami E, Schultz N, Soslow RA

  • Am J Surg Pathol. 2013 Jan;37(1):138-46.

2013-01-23

Fig (E). Serum autoantibodies to melanoma antigens showing positive titers to melanoma antigen A3 (MAGEA3) pre-ipilimumab.

Fig (E). Serum autoantibodies to melanoma antigens showing positive titers to melanoma antigen A3 (MAGEA3) pre-ipilimumab.
  • Stamell EF, Wolchok JD, Gnjatic S, Lee NY, Brownell I

  • Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):293-5.

2013-01-24

Fig 1. Temporal analysis of 89Zr-transferrin in tumor-bearing mice. (A) Representative PET images of tumor-bearing mouse show high and persistent uptake of 89Zr-transferrin in subcutaneous TS543 xenografts.

Fig 1. Temporal analysis of 89Zr-transferrin in tumor-bearing mice. (A) Representative PET images of tumor-bearing mouse show high and persistent uptake of 89Zr-transferrin in subcutaneous TS543 xenografts.
  • Evans MJ, Holland JP, Rice SL, Doran MG, Cheal SM, Campos C, Carlin SD, Mellinghoff IK, Sawyers CL, Lewis JS

  • J Nucl Med. 2013 Jan;54(1):90-5.

2013-01-25

Fig 1. Non–probe-based modalities for imaging of apoptosis.

Fig 1. Non–probe-based modalities for imaging of apoptosis.
  • Blankenberg FG, Strauss HW

  • J Nucl Med. 2013 Jan;54(1):1-4.

2013-01-28

Fig 7. Hydrodynamic modeling of Rep68* oligomerization.

Fig 7. Hydrodynamic modeling of Rep68* oligomerization.
  • Zarate-Perez F, Mansilla-Soto J, Bardelli M, Burgner JW 2nd, Villamil-Jarauta M, Kekilli D, Samso M, Linden RM, Escalante CR

  • J Virol. 2013 Jan;87(2):1232-41.

2013-01-29

Fig 3. Concept of combinatorial antigen recognition and balanced signaling for selective tumor eradication.

Fig 3. Concept of combinatorial antigen recognition and balanced signaling for selective tumor eradication.
  • Kloss CC, Condomines M, Cartellieri M, Bachmann M, Sadelain M

  • Nat Biotechnol. 2012 Dec 16;31(1):71-5.

2013-01-31

Fig 7b. Effects of aurora A shRNA knockdown on combined paclitaxel/pazopanib synergy.

Fig 7b. Effects of aurora A shRNA knockdown on combined paclitaxel/pazopanib synergy.
  • Isham CR, Bossou AR, Negron V, Fisher KE, Kumar R, Marlow L, Lingle WL, Smallridge RC, Sherman EJ, Suman VJ, Copland JA, Bible KC

  • Sci Transl Med. 2013 Jan 2;5(166):166ra3.

2013-02-01

Fig 1. Core CPMs of RT practice for gastric cancer.

Fig 1. Core CPMs of RT practice for gastric cancer.
  • Goodman KA, Khalid N, Kachnic LA, Minsky BD, Crozier C, Owen JB, Devlin PM, Thomas CR Jr

  • Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):355-62.

2013-02-04

Fig 3. a and b, 3D surface renderings show primary plane determination of calyceal groups.

Fig 3. a and b, 3D surface renderings show primary plane determination of calyceal groups.
  • Miller J, Durack JC, Sorensen MD, Wang JH, Stoller ML

  • J Urol. 2013 Feb;189(2):562-7.

2013-02-05

Fig 3a. OS by palifermin use.

Fig 3a. OS by palifermin use.
  • Goldberg JD, Zheng J, Castro-Malaspina H, Jakubowski AA, Heller G, van den Brink MR, Perales MA

  • Bone Marrow Transplant. 2013 Jan;48(1):99-104.

2013-02-06

Fig 1. Model of KLF6-SV1–driven metastasis.

Fig 1. Model of KLF6-SV1–driven metastasis.
  • Olson OC, Joyce JA

  • Sci Transl Med. 2013 Jan 23;5(169):169fs2.

2013-02-08

Fig 1. Histopathologic, immunohistochemical and cytogenetic findings of cutaneous clear cell sarcoma (CCS). Rearrangement of ATF1.

Fig 1. Histopathologic, immunohistochemical and cytogenetic findings of cutaneous clear cell sarcoma (CCS). Rearrangement of ATF1.
  • Sidiropoulos M, Busam K, Guitart J, Laskin WB, Wagner AM, Gerami P

  • J Cutan Pathol. 2013 Feb;40(2):265-8.

2013-02-11

Fig 1. Growth curves of HT29 human colorectal xenograft tumors grown subcutaneously in rats and treated for 26 days by the daily administration of vehicle or cediranib at doses of 0.75, 1.5 and 3 mg/kg (n = 6 in each group).

Fig 1. Growth curves of HT29 human colorectal xenograft tumors grown subcutaneously in rats and treated for 26 days by the daily administration of vehicle or cediranib at doses of 0.75, 1.5 and 3 mg/kg (n = 6 in each group).
  • Bokacheva L, Kotedia K, Reese M, Ricketts SA, Halliday J, Le CH, Koutcher JA, Carlin S

  • NMR Biomed. 2013 Feb;26(2):151-63.

2013-02-12

Fig 3. Incidence proportion of rectum cancer after a diagnosis of prostate carcinoma (PCa) is illustrated according to PCa stage. ICD154 indicates International Classification of Diseases code 154.

Fig 3. Incidence proportion of rectum cancer after a diagnosis of prostate carcinoma (PCa) is illustrated according to PCa stage. ICD154 indicates International Classification of Diseases code 154.
  • Van Hemelrijck M, Drevin L, Holmberg L, Garmo H, Adolfsson J, Stattin P.

  • Cancer. 2012 Dec 15;118(24):6207-16.

2013-02-13

Fig 1. TAMs and CAFs densely infiltrate thyroid tissue during BRAF-induced PTC initiation.

Fig 1. TAMs and CAFs densely infiltrate thyroid tissue during BRAF-induced PTC initiation.
  • Ryder M, Gild M, Hohl TM, Pamer E, Knauf J, Ghossein R, Joyce JA, Fagin JA

  • PLoS One. 2013;8(1):e54302.
Open Access button

2013-02-15

Fig 1. Ratio of fat to fat + water (FFW) versus histologic liver steatosis grade in 18 patients (19 tissue samples).

Fig 1. Ratio of fat to fat + water (FFW) versus histologic liver steatosis grade in 18 patients (19 tissue samples).
  • Qi J, Fong Y, Saltz L, D'Angelica MI, Kemeny NE, Gonen M, Shia J, Shukla-Dave A, Jarnagin WM, Do RK, Schwartz LH, Koutcher JA, Zakian KL

  • NMR Biomed. 2013 Feb;26(2):204-12.

2013-02-18

Fig 1. Derivation and mechanism of action of viral replicon particles (VRP) used in the study.

Fig 1. Derivation and mechanism of action of viral replicon particles (VRP) used in the study.
  • Slovin SF, Kehoe M, Durso R, Fernandez C, Olson W, Gao JP, Israel R, Scher HI, Morris S

  • Vaccine. 2013 Jan 30;31(6):943-9.

2013-02-19

Fig 1. Fundus appearance of the left eye as of the first recurrence. Note active tumor inferiorly, and scattered vitreous seeds.

Fig 1. Fundus appearance of the left eye as of the first recurrence. Note active tumor inferiorly, and scattered vitreous seeds.
  • Brodie SE, Munier FL, Francis JH, Marr B, Gobin YP, Abramson DH

  • Doc Ophthalmol. 2013 Feb;126(1):79-84.

2013-02-19

Fig. 1. Axial view of planning computed tomography scan; the bladder is outlined in white and the rectum is outlined in black; the white arrow marks the vaginal contrast demarcating the vaginal cuff.

Fig. 1. Axial view of planning computed tomography scan; the bladder is outlined in white and the rectum is outlined in black; the white arrow marks the vaginal contrast demarcating the vaginal cuff.
  • Folkert MR, Shih KK, Abu-Rustum NR, Jewell E, Kollmeier MA, Makker V, Barakat RR, Alektiar KM

  • Gynecol Oncol. 2013 Feb;128(2):288-93.

2013-02-20

Fig 1. Large areas of necrosis effacing the lymph node architecture.

Fig 1. Large areas of necrosis effacing the lymph node architecture.
  • Rosado FG, Tang YW, Hasserjian RP, McClain CM, Wang B, Mosse CA

  • Hum Pathol. 2013 Feb;44(2):255-9.

2013-02-21

Fig 1. Left to right: MRI T2-weighted (T2w) images showing the MRS voxel (white) positioned in the striatum region, and TE = 12 ms and TE = 136 ms spectra [short (STE) and long (LTE) TE, respectively) acquired from a C57BL/6 wild-type (WT) mouse brain (A) and from one group A GL261 tumor-bearing mouse brain at day 16 post-inoculation (B), 30 min after intragastric administration of dimethyl sulfoxide (DMSO).

Fig 1. Left to right: MRI T2-weighted (T2w) images showing the MRS voxel (white) positioned in the striatum region, and TE = 12 ms and TE = 136 ms spectra [short (STE) and long (LTE) TE, respectively) acquired from a C57BL/6 wild-type (WT) mouse brain (A) and from one group A GL261 tumor-bearing mouse brain at day 16 post-inoculation (B), 30 min after intragastric administration of dimethyl sulfoxide (DMSO).
  • Delgado-Goñi T, Martín-Sitjar J, Simões RV, Acosta M, Lope-Piedrafita S, Arús C

  • NMR Biomed. 2013 Feb;26(2):173-84.

2013-02-22

Fig 1. Minimal margin evaluation method. Minimal margin (M) is the minimum of n margin values (m): m1 = a1–b1, a2–b2, a3–b3, etc. In this demonstrated case, “a3–b3” represents the minimal margin.

Fig 1. Minimal margin evaluation method. Minimal margin (M) is the minimum of n margin values (m): m1 = a1–b1, a2–b2, a3–b3, etc. In this demonstrated case, “a3–b3” represents the minimal margin.
  • Wang X, Sofocleous CT, Erinjeri JP, Petre EN, Gonen M, Do KG, Brown KT, Covey AM, Brody LA, Alago W, Thornton RH, Kemeny NE, Solomon SB

  • Cardiovasc Intervent Radiol. 2013 Feb;36(1):166-75.

2013-02-25

Fig 1. Receiver operating characteristic (ROC) curve assessing the discrimination of the nomogram. The area under the ROC curve was 0.67.

Fig 1. Receiver operating characteristic (ROC) curve assessing the discrimination of the nomogram. The area under the ROC curve was 0.67.
  • van la Parra RF, Francissen CM, Peer PG, Ernst MF, de Roos WK, Van Zee KJ, Bosscha K

  • Eur J Cancer. 2013 Feb;49(3):564-71.

2013-02-26

Fig 1. Four lesions were created per pig in a right cranial (A), left cranial (B), right caudal (C), and left caudal (D) position.

Fig 1. Four lesions were created per pig in a right cranial (A), left cranial (B), right caudal (C), and left caudal (D) position.
  • Schoellnast H, Monette S, Ezell PC, Single G, Maybody M, Weiser MR, Fong Y, Solomon SB

  • Cardiovasc Intervent Radiol. 2013 Feb;36(1):213-20.

2013-02-27

Fig 2a. Histologic section from a patient's lesion. Patient without large cell transformation.

Fig 2a. Histologic section from a patient's lesion. Patient without large cell transformation.
  • Thomas TO, Agrawal P, Guitart J, Rosen ST, Rademaker AW, Querfeld C, Hayes JP, Kuzel TM, Mittal BB

  • Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):747-53.

2013-02-28

Fig 5a. Mitochondrial localization of cytosolic IDH1 mutant results in greater accumulation of 2HG in cells.

Fig 5a. Mitochondrial localization of cytosolic IDH1 mutant results in greater accumulation of 2HG in cells.
  • Ward PS, Lu C, Cross JR, Abdel-Wahab O, Levine RL, Schwartz GK, Thompson CB

  • J Biol Chem. 2013 Feb 8;288(6):3804-15.

2013-03-01

Fig 1. Comparison between hypofractionated stereotactic radiation therapy (HSRT) plan and magnetic resonance imaging (MRI) before treatment, during treatment, and at the time of recurrence.

Fig 1. Comparison between hypofractionated stereotactic radiation therapy (HSRT) plan and magnetic resonance imaging (MRI) before treatment, during treatment, and at the time of recurrence.
  • Shapiro LQ, Beal K, Goenka A, Karimi S, Iwamoto FM, Yamada Y, Zhang Z, Lassman AB, Abrey LE, Gutin PH

  • Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):636-42.

2013-03-04

Fig 2. Iodine-124 PET-CT Scans Obtained before and after Selumetinib Treatment in Selected Patients with Positive Responses.

Fig 2. Iodine-124 PET-CT Scans Obtained before and after Selumetinib Treatment in Selected Patients with Positive Responses.
  • Ho AL, Grewal RK, Leboeuf R, Sherman EJ, Pfister DG, Deandreis D, Pentlow KS, Zanzonico PB, Haque S, Gavane S, Ghossein RA, Ricarte-Filho JC, Domínguez JM, Shen R, Tuttle RM, Larson SM, Fagin JA

  • N Engl J Med. 2013 Feb 14;368(7):623-32.

2013-03-05

Fig 7. Mean International Prostate Symptom Score (IPSS) as a function of time after I-125 implantation.

Fig 7. Mean International Prostate Symptom Score (IPSS) as a function of time after I-125 implantation.
  • Hanin L, Zaider M

  • Phys Med Biol. 2013 Feb 21;58(4):825-39.

2013-03-06

Fig 6. Stable miR-21 represses PDCD4 and enhances AP-1 activity upon growth-factor restimulation. (E)AP-1 activity measured 12 h following IL-3 restimulation, as in C, using a reporter containing 6 tandem AP-1 binding sites upstream of firefly luciferase.

Fig 6. Stable miR-21 represses PDCD4 and enhances AP-1 activity upon growth-factor restimulation. (E)AP-1 activity measured 12 h following IL-3 restimulation, as in C, using a reporter containing 6 tandem AP-1 binding sites upstream of firefly luciferase.
  • Olejniczak SH, La Rocca G, Gruber JJ, Thompson CB

  • Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):157-62.

2013-03-07

Fig 4. PSA removal antagonized the specific effect of CIS on dendritic branches.

Fig 4. PSA removal antagonized the specific effect of CIS on dendritic branches.
  • McCall T, Weil ZM, Nacher J, Bloss EB, El Maarouf A, Rutishauser U, McEwen BS

  • Exp Neurol. 2012 Dec 7;241C:5-12.

2013-03-08

Fig 2a. Chart showing plausible growth dynamics of congenital melanocytic nevi (CMN) diameter from birth to adulthood.

Fig 2a. Chart showing plausible growth dynamics of congenital melanocytic nevi (CMN) diameter from birth to adulthood.
  • Krengel S, Scope A, Dusza SW, Vonthein R, Marghoob AA

  • J Am Acad Dermatol. 2013 Mar;68(3):441-51.

2013-03-11

Fig 1. F-actin organization in resting and activated macrophages.

Fig 1. F-actin organization in resting and activated macrophages.
  • Ali WH, Chen Q, Delgiorno KE, Su W, Hall JC, Hongu T, Tian H, Kanaho Y, Di Paolo G, Crawford HC, Frohman MA

  • PLoS One. 2013;8(1):e55325.
Open Access button

2013-03-12

Fig 1. The quality circle for healthcare improvement.

Fig 1. The quality circle for healthcare improvement.
  • Kremer LC, Mulder RL, Oeffinger KC, Bhatia S, Landier W, Levitt G, Constine LS, Wallace WH, Caron HN, Armenian SH, Skinner R, Hudson MM

  • Pediatr Blood Cancer. 2013 Apr;60(4):543-9.

2013-03-13

Fig 2. Comparison of ADV viral load (VL) in patients with ADV viremia without disease (ADV viremia only) and those with ADV disease.

Fig 2. Comparison of ADV viral load (VL) in patients with ADV viremia without disease (ADV viremia only) and those with ADV disease.
  • Lee YJ, Chung D, Xiao K, Papadopoulos EB, Barker JN, Small TN, Giralt SA, Zheng J, Jakubowski AA, Papanicolaou GA

  • Biol Blood Marrow Transplant. 2013 Mar;19(3):387-92.

2013-03-14

Fig 1h. Dedifferentiated GIST (case #1) showing a conventional, spindle cell component and 2 SNPs in intron 17.

Fig 1h. Dedifferentiated GIST (case #1) showing a conventional, spindle cell component and 2 SNPs in intron 17.
  • Antonescu CR, Romeo S, Zhang L, Nafa K, Hornick JL, Nielsen GP, Mino-Kenudson M, Huang HY, Mosquera JM, Tos PA, Fletcher CD

  • Am J Surg Pathol. 2013 Mar;37(3):385-92.

2013-03-15

Fig 1a. The properties of an amplicon driver. Amplicon drivers should map to the smallest region of amplification (SRA) here depicted in a heatmap of gains (light red), losses (light blue), amplifications (dark red), and deletions (dark blue) with the SRA highlighted in yellow.

Fig 1a. The properties of an amplicon driver. Amplicon drivers should map to the smallest region of amplification (SRA) here depicted in a heatmap of gains (light red), losses (light blue), amplifications (dark red), and deletions (dark blue) with the SRA highlighted in yellow.
  • Wilkerson PM, Reis-Filho JS

  • Genes Chromosomes Cancer. 2013 Apr;52(4):333-55.

2013-03-18

Fig 1. Axial CT view demonstrating a sacral insufficiency fracture.

Fig 1. Axial CT view demonstrating a sacral insufficiency fracture.
  • Shih KK, Folkert MR, Kollmeier MA, Abu-Rustum NR, Sonoda Y, Leitao MM Jr, Barakat RR, Alektiar KM

  • Gynecol Oncol. 2013 Mar;128(3):540-3.

2013-03-19

Fig 6. p53 expression. A, Overexpression. B, Null pattern. C, Focal expression. Patterns A and B, aberrant expression patterns, are tightly associated with TP53 mutation, whereas pattern C is not.

Fig 6. p53 expression. A, Overexpression. B, Null pattern. C, Focal expression. Patterns A and B, aberrant expression patterns, are tightly associated with TP53 mutation, whereas pattern C is not.
  • Karamurzin Y, Leitao MM Jr, Soslow RA

  • Am J Surg Pathol. 2013 Mar;37(3):356-67.

2013-03-20

Fig 2.Time to regulatory authority approval according to geographical (A) and economic (B) regions.

Fig 2.Time to regulatory authority approval according to geographical (A) and economic (B) regions.
  • Metzger-Filho O, de Azambuja E, Bradbury I, Saini KS, Bines J, Simon SD, Dooren VV, Aktan G, Pritchard KI, Wolff AC, Smith I, Jackisch C, Lang I, Untch M, Boyle F, Xu B, Baselga J, Perez EA, Piccart-Gebhart M

  • Oncologist. 2013;18(2):134-40.

2013-03-21

Fig 2.Summary of parameter dependencies and digital/analog response for the deterministic system. (A, B, and E)

Fig 2.Summary of parameter dependencies and digital/analog response for the deterministic system. (A, B, and E)
  • François P, Voisinne G, Siggia ED, Altan-Bonnet G, Vergassola M

  • Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):E888-97.

2013-03-22

Fig 1.Identification of novel DAP proteins.(D) Subcellular distribution of CEP83. RPE-1 cells stably expressing GFP-centrin 2 (green) were stained with an antibody to CEP83 (red) and DAPI (blue).

Fig 1.Identification of novel DAP proteins.(D) Subcellular distribution of CEP83. RPE-1 cells stably expressing GFP-centrin 2 (green) were stained with an antibody to CEP83 (red) and DAPI (blue).
  • Tanos BE, Yang HJ, Soni R, Wang WJ, Macaluso FP, Asara JM, Tsou MF

  • Genes Dev. 2013 Jan 15;27(2):163-8

2013-03-25

Fig 2.Cfl1C5 enhances the convergent extension defect in the Vangl2Lp notochord. (A-D) Projections of flat-mounted E8.0 embryos stained for brachyury (T) (magenta).

Fig 2.Cfl1C5 enhances the convergent extension defect in the Vangl2Lp notochord. (A-D) Projections of flat-mounted E8.0 embryos stained for brachyury (T) (magenta).
  • Mahaffey JP, Grego-Bessa J, Liem KF Jr, Anderson KV

  • Development. 2013 Mar;140(6):1262-71.

2013-03-26

Fig 4.The state of β-catenin during self-renewal and differentiation in mESCs. (D) Confocal images of TLG cells grown in serum+LIF.

Fig 4.The state of β-catenin during self-renewal and differentiation in mESCs. (D) Confocal images of TLG cells grown in serum+LIF.
  • Faunes F, Hayward P, Descalzo SM, Chatterjee SS, Balayo T, Trott J, Christoforou A, Ferrer-Vaquer A, Hadjantonakis AK, Dasgupta R, Arias AM

  • Development. 2013 Mar;140(6):1171-83.
Open Access button

2013-03-27

Fig 1. Homogenous labeling of metastatic melanoma for BRAFV600E. All tumor cells in the lymph node show strong cytoplasmic labeling with the antibody VE1.

Fig 1. Homogenous labeling of metastatic melanoma for BRAFV600E. All tumor cells in the lymph node show strong cytoplasmic labeling with the antibody VE1.
  • Busam KJ, Hedvat C, Pulitzer M, von Deimling A, Jungbluth AA

  • Am J Surg Pathol. 2013 Mar;37(3):413-20.

2013-03-28

Fig 6. Effects of various compounds on cell-cycle progression in CL141T cells.

Fig 6. Effects of various compounds on cell-cycle progression in CL141T cells.
  • Chaniyara R, Tala S, Chen CW, Zang X, Kakadiya R, Lin LF, Chen CH, Chien SI, Chou TC, Tsai TH, Lee TC, Shah A, Su TL

  • J Med Chem. 2013 Feb 14.

2013-03-29

Fig 1. Unadjusted Kaplan-Meier curves for prostate-specific antigen (PSA) relapse-free survival among metformin, diabetic non-metformin, and nondiabetic groups.

Fig 1. Unadjusted Kaplan-Meier curves for prostate-specific antigen (PSA) relapse-free survival among metformin, diabetic non-metformin, and nondiabetic groups.
  • Spratt DE, Zhang C, Zumsteg ZS, Pei X, Zhang Z, Zelefsky MJ

  • Eur Urol. 2013 Apr;63(4):709-16.

2013-04-01

Fig 1. Physicians who performed UD by log year and certification type.

Fig 1. Physicians who performed UD by log year and certification type.
  • Silberstein JL, Poon SA, Maschino AC, Lowrance WT, Garg T, Herr HW, Donat SM, Dalbagni G, Bochner BH, Sandhu JS

  • J Urol. 2013 Mar;189(3):1042-7.